{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:48:50Z","timestamp":1792828130805,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40265-018-1018-z","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T08:04:54Z","timestamp":1548921894000},"page":"5-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":287,"title":["Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles"],"prefix":"10.1007","volume":"79","author":[{"given":"Karin","family":"Weissenborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"1018_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715\u201335.","journal-title":"Hepatology"},{"issue":"2","key":"1018_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","volume":"62","author":"M Romero-G\u00f3mez","year":"2015","unstructured":"Romero-G\u00f3mez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62(2):437\u201347.","journal-title":"J Hepatol"},{"issue":"5","key":"1018_CR3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.20905","volume":"42","author":"O Riggio","year":"2005","unstructured":"Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42(5):1158\u201365.","journal-title":"Hepatology"},{"issue":"114","key":"1018_CR4","first-page":"135","volume":"36","author":"A Read","year":"1967","unstructured":"Read A, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med. 1967;36(114):135\u201350.","journal-title":"Q J Med"},{"issue":"4","key":"1018_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jhep.2012.11.043","volume":"58","author":"AB Tryc","year":"2013","unstructured":"Tryc AB, Goldbecker A, Berding G, R\u00fcmke S, Afshar K, Shahrezaei GH, et al. Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol. 2013;58(4):698\u2013705.","journal-title":"J Hepatol"},{"issue":"5","key":"1018_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","volume":"34","author":"K Weissenborn","year":"2001","unstructured":"Weissenborn K, Ennen JC, Schomerus H, R\u00fcckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768\u201373.","journal-title":"J Hepatol"},{"key":"1018_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1019-y","author":"S Montagnese","year":"2018","unstructured":"Montagnese S, Bajaj JS. Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues. Drugs 2018. \n                    https:\/\/doi.org\/10.1007\/s40265-018-1019-y\n                    \n                  .","journal-title":"Drugs"},{"issue":"Suppl 1","key":"1018_CR8","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.jceh.2014.06.005","volume":"5","author":"K Weissenborn","year":"2015","unstructured":"Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):S54\u20139.","journal-title":"J Clin Exp Hepatol."},{"issue":"3","key":"1018_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jhep.2008.06.023","volume":"49","author":"K Weissenborn","year":"2008","unstructured":"Weissenborn K. PHES: one label, different goods?! J Hepatol. 2008;49(3):308\u201312.","journal-title":"J Hepatol"},{"issue":"1","key":"1018_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.29146","volume":"66","author":"F Campagna","year":"2017","unstructured":"Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, et al. The animal naming test: an easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017;66(1):198\u2013208.","journal-title":"Hepatology"},{"issue":"6","key":"1018_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11011-015-9726-5","volume":"31","author":"MY Morgan","year":"2016","unstructured":"Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, et al. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis. 2016;31(6):1217\u201329.","journal-title":"Metab Brain Dis"},{"issue":"42","key":"1018_CR12","doi-asserted-by":"publisher","first-page":"15756","DOI":"10.3748\/wjg.v20.i42.15756","volume":"20","author":"S Montagnese","year":"2014","unstructured":"Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, et al. Covert hepatic encephalopathy: agreement and predictive validity of different indices. World J Gastroenterol. 2014;20(42):15756\u201362.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1018_CR13","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s10620-010-1249-7","volume":"55","author":"RK Dhiman","year":"2010","unstructured":"Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55(8):2381\u201390.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1018_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/hep.21586","volume":"45","author":"M Romero-G\u00f3mez","year":"2007","unstructured":"Romero-G\u00f3mez M, C\u00f3rdoba J, Jover R, del Olmo JA, Ram\u00edrez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45(4):879\u201385.","journal-title":"Hepatology"},{"issue":"10","key":"1018_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2012-303262","volume":"62","author":"A Goldbecker","year":"2013","unstructured":"Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, R\u00fcmke S, Barg-Hock H, et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut. 2013;62(10):1497\u2013504.","journal-title":"Gut"},{"issue":"1","key":"1018_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/hep.27127","volume":"61","author":"S Montagnese","year":"2015","unstructured":"Montagnese S, Schiff S, Amodio P. Quick diagnosis of hepatic encephalopathy: fact or fiction? Hepatology. 2015;61(1):405\u20136.","journal-title":"Hepatology"},{"issue":"2","key":"1018_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11064-014-1416-x","volume":"40","author":"K Weissenborn","year":"2015","unstructured":"Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res. 2015;40(2):265\u201373.","journal-title":"Neurochem Res"},{"issue":"4","key":"1018_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jhep.2016.11.021","volume":"66","author":"S Montagnese","year":"2017","unstructured":"Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is \u201cnormal\u201d? J Hepatol. 2017;66(4):825\u201335.","journal-title":"J Hepatol"},{"issue":"2","key":"1018_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1053\/gast.2003.50062","volume":"124","author":"K Weissenborn","year":"2003","unstructured":"Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, et al. Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology. 2003;124(2):346\u201351.","journal-title":"Gastroenterology"},{"issue":"3","key":"1018_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11011-018-0191-9","volume":"33","author":"XD Zhang","year":"2018","unstructured":"Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661\u201371.","journal-title":"Metab Brain Dis"},{"key":"1018_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1017-0","author":"RF Butterworth","year":"2018","unstructured":"Butterworth RF. Hepatic encephalopathy in cirrhosis: pathology and pathophysiology. Drugs 2018. \n                    https:\/\/doi.org\/10.1007\/s40265-018-1017-0\n                    \n                  .","journal-title":"Drugs"},{"issue":"3","key":"1018_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3174\/ajnr.A4146","volume":"36","author":"HJ Chen","year":"2015","unstructured":"Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH. Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining. AJNR Am J Neuroradiol. 2015;36(3):481\u20137.","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-018-1018-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-018-1018-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-018-1018-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T19:24:43Z","timestamp":1580412283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-018-1018-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":22,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1007\/s40265-018-1018-z","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"31 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This supplement to <i>Drugs<\/i> has been wholly funded by Merz Pharmaceuticals GmbH, Frankfurt, Germany.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"KW has received grants and personal fees from Boehringer Ingelheim and Abbvie, and personal fees from Merz Pharmaceuticals GmbH, Novartis, and BMS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}